共 19 条
[1]
A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. Haase I,Hobbs RM,Romero MR,et al. The Journal of Clinical Investigation . 2001
[2]
Chemokine receptors and their role in inflammation and infectious diseases. Murdoch C,Finn A. Blood . 2000
[3]
New targets for anti-inflammatory drugs. Lewis AJ,Manning AM. Current Opinion in Chemical Biology . 1999
[4]
Psoriatic keratinocytes show reduced IRF- 1 and STAT- 1alpha activation in response to gamma-IFN. Jackson M,Howie SE,Weller R,et al. The FASEB Journal . 1999
[5]
Interleukin 6 and its receptor: ten years later. Hirano T. International Reviews of Immunology . 1998
[6]
Increased activation of Ras in psoriatic lesions. Lin P,Baldassare JJ,Voorhees JJ,et al. Skin Pharmacology and Applied Skin Physiology . 1999
[7]
Lck inhibitors as a therapeutic approach to autoimmune disease and transplant rejection. Kamens JS,Ratnofsky SE,Hirst GC. Current Opinion in Investigational Drugs . 2001
[8]
IL- 2 signaling in human monocytes involves the phosphorylation and activation of p59hck. Bosco MC,Curiel RE,Zea AH,et al. J Immunol . 2000
[9]
ascularpermeabilityfactor/vascularendothelialgrowthfactor,microvascularhyperpermeabilityandangiogenesis. DvorakHF,BrownLF,DetmarM,etal. American Journal of Pathology . 1995
[10]
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Fong TA,Shawver LK,Sun L,et al. Cancer Research . 1999